Parnax Lab

Parnax Lab P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Parnax Lab (506128.BO) as of Nov 14, 2026 is 4.42. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 8.99 — a change of -50.85% (lower).

P/CF

4.42

YoY

-50.85%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Parnax Lab is 2025 4.42 . P/CF (Price-to-Cash-Flow Ratio) of Parnax Lab was 2024 8.99 . It decreases by -50.85% lower compared to the previous year.

The Parnax Lab P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
11.08 INR
Jan 1, 2019
16.38 INR
Jan 1, 2020
16.32 INR
Jan 1, 2021
22.63 INR
Jan 1, 2022
16.70 INR
Jan 1, 2023
6.83 INR
Jan 1, 2024
8.99 INR
Jan 1, 2025
4.42 INR
The Parnax Lab P/CF history
YEARP/CFYoY
4.42-50.85%
8.99+31.70%
6.83-59.13%
16.70-26.17%
22.63+38.62%
16.32-0.34%
16.38+47.82%
11.08-10.42%
12.37-69.80%
40.96-107.21%
-568.27-41.52%
-971.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

P/CF (Price-to-Cash-Flow Ratio) of Parnax Lab is 4.42 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Parnax Lab changed from 8.99 to 4.42, representing a -50.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab